289505-18-6Relevant articles and documents
Novel aminoglycosides and uses thereof in the treatment of genetic disorders
-
Page/Page column 20; 34-35, (2009/04/24)
A new class of paromomycin-derived aminoglycosides, which exhibit efficient stop-codon mutation suppression activity, low toxicity and high selectivity towards eukaryotic cells are provided. Also provided are chemical and chemo-enzymatic processes of preparing these paromomycin-derived aminoglycosides and intermediates thereof, as well as pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic disorders.
Efficient synthesis of neomycin B related aminoglycosides
Ding, Yili,Swayze, Eric E.,Hofstadler, Steven A.,Griffey, Richard H.
, p. 4049 - 4052 (2007/10/03)
Aminoglycosides 6'-hydroxyl-ribostamycin and 5-(α-neobiosamine)-2- deoxystreptamine were chemically synthesized. These compounds will be used as standards to compare RNA binding affinity and specificity with neomycin B. (C) 2000 Elsevier Science Ltd.